lipid lowering drugs

WARRIOR Underscores Burden of Nonobstructive Angina in Women

by

In women with signs of ischemia but no obstructive coronary artery disease (OCAD), intensive medical therapy did not reduce the first occurrence of a major cardiovascular event in the WARRIOR trial, but the trial was underpowered to show a definitive result. “This is a neutral trial and should not be considered a negative trial,” said … Read more

Cardiovascular Risk in T1D: LDL Focus and Beyond

by

Estimation of cardiovascular risk (CVR) in individuals living with type 1 diabetes (T1D) was a key topic presented by Sophie Borot, MD, from Besançon University Hospital, Besançon, France, at the 40th congress of the French Society of Endocrinology. Borot highlighted the complexities of this subject, outlining several factors that contribute to its challenges. A Heterogeneous … Read more